Today's Family to Feature PARI Respiratory Equipment Inc.
Deerfield Beach, FL, September 04, 2008 --(
PR.com)-- The producers of Today’s Family, an innovative, educational series, are pleased to announce that they will feature PARI Respiratory Equipment, Inc. in a segment on “Healthy Living,” as part of the show’s “Breathe Easier” series. The segment is part of a half-hour show that will air on Oxygen on Saturday, September 6, 2008 at 6:00 a.m. ET & PT, at 5:00 a.m. CT and at 4:00 a.m. MT.
Chronic Obstructive Pulmonary Disease, also known as COPD, is the fourth leading cause of death in America, behind heart disease, cancer, and stroke. It is estimated that approximately 12 million Americans have been diagnosed with the disease, and at least another 12 million have symptoms, but have not been diagnosed.
While the most common forms of the disease are chronic bronchitis and emphysema, the term COPD refers to a number of chronic lung disorders, in which the airways to the lungs become narrowed, and breathing becomes progressively difficult. It is not uncommon for patients to suffer from both chronic bronchitis and emphysema.
Helping patients breathe easier, PARI is a worldwide leader of fast and efficient aerosol delivery systems to treat respiratory diseases such as COPD. The company has its North American headquarters in Midlothian, Virginia, and its worldwide headquarters in Starnberg, Germany.
“Our vision is to improve the lives of those affected by respiratory diseases and those who care for them,” states Geoff A. Hunziker, President of PARI Respiratory Equipment, Inc.
PARI provides the world’s leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI LC Sprint nebulizer line. The company also manufactures the award-winning PARI Trek S compact compressor, the innovative aerosol mask Bubbles the Fish II, and the PARI PRONEB Ultra II.
Nebulization is easy to do and does not require any special breathing technique to master in order to get a therapeutic dose. In addition, nebulization is an effective method of delivering medication directly into the lungs. Many COPD patients prefer to use them, especially as their symptoms worsen. Recently, two new medications have been approved for COPD symptoms, one from Sepracor (Brovana) and one from Dey LP (Perforomist). Both products used PARI Nebulizers exclusively in all the pivotal clinical trials that proved safety and efficacy. These companies chose PARI products based on PARI’s long track record of clinical trial experience for safety and efficacy.
To learn more about PARI Respiratory, log on to www.pari.com. Or call 1-800-FAST NEB.
Contact: Public Relations
Today's Family
800-597-1186
###
